|
|
Volumn 14, Issue 3, 1996, Pages 697-699
|
|
Should we treat her, too?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY HER2;
TAMOXIFEN;
UNCLASSIFIED DRUG;
ANTIBODY SPECIFICITY;
BREAST CANCER;
CANCER HORMONE THERAPY;
DRUG RESEARCH;
EDITORIAL;
GENE THERAPY;
HUMAN;
MOLECULAR BIOLOGY;
PRIORITY JOURNAL;
PROGNOSIS;
PROTO ONCOGENE;
|
|
EID: 0029883810
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.1996.14.3.697 Document Type: Editorial |
|
Times cited : (8)
|
|
References (0)
|
